L-kynurenine as a prognostic marker for early mortality in patients with acute myeloid leukemia

Leuk Lymphoma. 2022 Aug;63(8):2001-2004. doi: 10.1080/10428194.2022.2053534. Epub 2022 Mar 31.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Kynurenine*
  • Leukemia, Myeloid, Acute*
  • Prognosis

Substances

  • Kynurenine